LEO 29102

DRUG4 trials

Sponsors

LEO Pharma

Conditions

Atopic Dermatitis

Phase 1

LEO 29102 Single and Multiple Dose Study by Dermal Application

CompletedNCT00891709

LEO PharmaAtopic Dermatitis

Start: 2009-03-31End: 2009-06-30Updated: 2025-02-24

Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102

CompletedNCT01423656

LEO PharmaAtopic Dermatitis

Start: 2011-08-31End: 2012-11-30Updated: 2025-02-24

Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.

TerminatedNCT01447758

LEO PharmaAtopic Dermatitis

Start: 2011-09-30End: 2013-03-31Updated: 2025-02-24

Phase 2

LEO 29102 Cream in the Treatment of Atopic Dermatitis

CompletedNCT01037881

LEO PharmaAtopic Dermatitis

Start: 2009-12-31End: 2010-06-30Updated: 2025-03-10